Curatio Healthcare

Established in 2005, Curatio Healthcare is a specialty pharmaceutical company focused on dermatology. The company was founded in Chennai, India, by G.K. Ramani, K.R. Krishna, and R.K. Ramanathan, a team of former executives from American Remedies. Their objective was to address therapy gaps within general and cosmetic dermatology by using market research to identify needs and develop corresponding products.

The company operates in the cosmetic dermatology market, serving dermatologists, pediatricians, and cosmetologists. Its business model revolves around developing, manufacturing, and marketing a portfolio of over 50 brands. Revenue is generated through the sale of these products via a distribution network of over 900 stockists and a field force of medical representatives who engage with doctors. In September 2022, Torrent Pharmaceuticals signed a definitive agreement to acquire 100% of Curatio Healthcare for ₹2,000 crores (approximately $245 million). This acquisition positioned Torrent Pharma among the top 10 players in the Indian dermatology segment.

Curatio's product line includes skincare, haircare, and personal hygiene items for all age groups. The portfolio features prominent brands in pediatric and cosmetic dermatology, such as Tedibar, Atogla, Spoo, and B4 Nappi. Dermatology products account for 82% of the company's revenue, with its top ten brands contributing to approximately 75% of total sales. The company also has a presence in international markets, including Sri Lanka, Nepal, and the Philippines.

Keywords: dermatology, skincare, pharmaceuticals, cosmetic dermatology, pediatric dermatology, brand portfolio, Torrent Pharma, Indian pharma, G.K. Ramani, healthcare products